Human and Bacterial NDPKs as novel activators of the NLRP3 inflammasome: Implications for the biology and management of AML and MDS

Drayson, Mark (Co-Investigator)
Khanim, Farhat (Co-Investigator)
Bunce, Christopher (Principal Investigator)

Biosciences

Short title	Human and Bacterial NDPKs as novel activators of the NLRP3 inflammasome: Implications for the biology and management of AML and MDS
Status	Finished
Effective start/end date	2/04/18 → 31/12/21

Funding

BLOODWISE

1 Article

Pathogen and human NDPK-proteins promote AML cell survival via monocyte NLRP3-inflammasome activation
Trova, S., Lomada, S., Fenton, M., Chauhan, B., Adams, A., Puri, A., Di Maio, A., Wieland, T., Sewell, D., Dick, K., Wiseman, D., Wilks, D., Goodall, M., Drayson, M., Khanim, F. & Bunce, C., 7 Jul 2023, In: PLoS ONE. 18, 7, 23 p., e0288162.
Research output: Contribution to journal › Article › peer-review

Open Access
File
13 Downloads (Pure)